Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors

Polish Journal of Pathology

Volumn 55, Issue 4, 2004, Pages 149-153

  Ferenc, Tomasz ^a,e   Lewiński, Andrzej ^a   Lange, Dariusz ^b   Niewiadomska, Hanna ^a   Sygut, Jacek ^c   Sporny, Stanisław ^a   Włoch, Jan ^b   Salacinska Los, Elzbieta ^a   Kulig, Andrzej ^d   Jarza̧b, Barbara ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Swietokrzyskie Centrum Onkologii Poland   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^e Department of Biology and Genetics ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NM23 H1; NUCLEOSIDE DIPHOSPHATE KINASE A; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NODULAR GOITER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; GENES, TUMOR SUPPRESSOR; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEOSIDE-DIPHOSPHATE KINASE; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 20044396717     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Leone A, McBride OW, Weston A et al: Somatic allelic deletion of nm23 in human cancer. Cancer Res 1991, 51, 2490-2493.
2. Martinez R, Venturelli D, Perotti D et al: Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family. Cancer Res 1997, 57, 1180-1187.
3. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Vernon M, Strahler J: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 1992, 89, 919-924.
4. Caligo MA, Cipollini G, Fiore L et al: Nm23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 1995, 60, 837-842.
5. Cheah PY, Cao X, Eu KW, Seow-Choen F: Nm23-H1 immunostaining is inversely associated with tumor staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer 1998, 77, 1164-1168.
6. Lee CS, Redshaw A, Boag C: Nm23-H1 protein immunoreactivity in laryngeal carcinoma. Cancer 1996, 77, 2246-2250.
7. Takino H, Herman V, Weiss M, Melmed S: Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. J Clin Endocrinol Metab 1995, 80, 1733-1738.
8. Saitoh K, Takahashi H, Yamamoto M, Kishi H, Parsons PG: Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumor progression in human malignant melanomas. Histopathology 1996, 29, 497-505.
9. Betke H, Korabiowska M, Brinck U et al: The role of nm23 in melanoma progression and its prognostic significance. Pol J Pathol 1998, 49, 93-96.
10. Gunduz M, Ayhan A, Gullu I et al: Nm23 protein expression in larynx cancer and the relationship with metastasis. Eur J Cancer 1997, 33, 2338-2341.
11. Hiasa Y, Konishi N, Tao M et al: Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma. Oncology 1996, 53, 79-87.
12. Nakagawa Y, Tsumatani K, Kurumatani N et al: Prognostic value of nm23 protein expression in renal cell carcinomas. Oncology 1998, 55, 370-376.
13. Bertheau P, De La Rosa A, Merino MJ: Nm23 protein in neoplastic and nonneoplastic thyroid tissues. Am J Pathol 1994, 145, 26-32.
14. Hedinger C, Williams ED, Sobin LH: Histological Typing of Thyroid Tumors. The WHO International Histological Classification of Tumors. 2nd rev ed. Springer-Verlag, Berlin 1988.
15. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981, 29, 577-580.
16. Fuita M, Enomoto T, Haba T et al: Alteration of p16 and p15 gene in common epithelial ovarian tumors. Int J Cancer 1997, 74, 148-155.
17. Zou M, Shhi Y, Al-Sedairy S, Farid NR: High levels of nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer 1993, 68, 385-388.
18. Arai T, Watanabe M, Onodera M et al: Reduced nm23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. Am J Pathol 1993, 142, 1938-1944.